Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100046891Phase 4Recruiting
Phase 4, randomised, open-label trial of propofol and alfentanil in gastrointestinal conditions (4 arms), sponsored by Liaoning Provincial People's Hospital. Primary endpoints: Gender, Age and 17 more. Started Jun 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100046891.